Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GH production naturally declines with age, potentially causing age-related symptoms
Semaglutide targets GLP-1 receptors to control appetite and blood sugar, while tirzepatide targets both GLP-1 and GIP receptors
The fundamental difference is the receptor pathway
maintaining hydration is important Common side effects (affecting up to 1 in 10 people): Vomiting Constipation Due to slowed gastric emptying Abdominal pain or discomfort Reduced appetite This is partly how the medication aids blood glucose control Indigestion or acid reflux Fatigue or dizziness Hypoglycaemia (low blood sugar) Particularly when used with other diabetes medications such as sulphonylureas or insulin Gallbladder problems Including gallstones When to seek medical advice: Contact your GP or diabetes team promptly if you experience: Severe, persistent abdominal pain particularly if radiating to the back, as this could indicate pancreatitis (rare but serious)
US$ 23.51
)
US$ 22.29
)
US$ 24.57
)
